Credits: BioSpectrum, 21 October 2020 Malaysia’s Medical Innovation Ventures (Mediven®) achieved 100% concordance for GenoAmp®, its COVID-19 PCR test kit in an international third party evaluation study External Quality Assessment (EQA) / Proficiency Testing (PT) from the UK. The study
Credits: Bernama, 8 May 2020, PENANG Medical Innovation Ventures Sdn Bhd (Mediven®) announced that both its real-time PCR kits for COVID-19 have been approved for sale in the European Union (EU). CE marking is a notification process to authorities which
Credits: Malaysiakini, 8 May 2020, KUALA LUMPUR Dua kit ujian Covid-19 yang dihasilkan sebuah syarikat Malaysia mendapat kelulusan untuk dijual di Kesatuan Eropah (EU). Medical Innovation Ventures Sdn Bhd (Mediven) berkata, kit ujian ‘GenoAmp Real-Time RT PCR SARS-CoV-2’
Credits: Astro Awani, 18 March 2020, KUALA LUMPUR — Medical Innovation Ventures Sdn. Bhd. (Mediven), a company under the Malaysian Technology Development Corporation (MTDC) ecosystem has produced two diagnostic kits for COVID-19 disease. The first kit serves as a screening
Credits: New Straits Times – March 25, 2020 — PUTRAJAYA: The Science, Technology, and Innovation Ministry (Mosti) has taken several initiatives to assist the Health Ministry (MoH) in its quest to contain the COVID-19 outbreak. Minister Khairy Jamaluddin said to
Credits: Bernama PUTRAJAYA, 25 March 2020 — The Ministry of Science, Technology, and Innovation (MOSTI) and the Higher Education Ministry (KPT) today announced the formation of a Special COVID-19 Screening Team to conduct tests in 10 diagnostic laboratories. MOSTI Minister Khairy Jamaluddin said the tests
Credits: The Edge markets March 27, 2020, By Vanessa Gomes —Malaysian companies develop COVID-19 rapid test kits A Malaysian company, Medical Innovation Ventures Sdn Bhd (Mediven), has developed a new laboratory test kit for use in testing patient specimens of
Credits: Find — We are collating an overview of all SARS-CoV-2 tests commercially available or in development for the diagnosis of COVID-19. We cannot guarantee that this is a fully comprehensive list.